Adding a fourth drug to the existing three drug antiretroviral treatment, for the initial stages of HIV has not shown any benefits, according to a U.S. study that covered some 765 patients for three years.
Researchers from the Medical College of Cornell University, said in an article published in the latest issue of the Journal of the American Medical Association, that there were no significant differences over three years between the standard 3-drug regimen and a new 4-drug regimen. Full Story...
Researchers from the Medical College of Cornell University, said in an article published in the latest issue of the Journal of the American Medical Association, that there were no significant differences over three years between the standard 3-drug regimen and a new 4-drug regimen. Full Story...
0 comments:
Post a Comment